StonvexLoading…
StonvexStonvexStonvexCore line items from ORLY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.56B | $17.78B | $13.37B | $8.66B |
Operating Income | $841.61M | $3.46B | $2.63B | $1.66B |
Net Income | $604.18M | $2.54B | $1.93B | $1.21B |
EPS (Diluted) | $0.72 | $2.97 | $2.25 | $1.40 |
Total Assets | $16.94B | $16.54B | $16.28B | $15.82B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $252.63M | $193.79M | $204.51M | $198.61M |
Free Cash Flow OCF − CapEx | $788.47M | $1.59B | $1.23B | $924.28M |
Shares Outstanding | 832.29M | 841.91M | 846.83M | 850.56M |